Commentary: Fluoroquinolones and aortopathy-a basic (science) question?

[1]  J. Coselli,et al.  Ciprofloxacin accelerates aortic enlargement and promotes dissection and rupture in Marfan mice. , 2020, The Journal of thoracic and cardiovascular surgery.

[2]  Chia‐Hsuin Chang,et al.  Association of Infections and Use of Fluoroquinolones With the Risk of Aortic Aneurysm or Aortic Dissection. , 2020, JAMA internal medicine.

[3]  R. Grant,et al.  Observational Study Design Challenges-The Case of Fluoroquinolones and Aortic Disease. , 2020, JAMA internal medicine.

[4]  J. Gagne,et al.  Association of Fluoroquinolones With the Risk of Aortic Aneurysm or Aortic Dissection. , 2020, JAMA internal medicine.

[5]  The United States Food and Drug Administration , 2019, Cobert's Manual of Drug Safety and Pharmacovigilance.

[6]  S. Lemaire,et al.  Patients at Risk for Aortic Rupture Often Exposed to Fluoroquinolones during Hospitalization , 2018, Antimicrobial Agents and Chemotherapy.

[7]  Chien-Chang Lee,et al.  Oral Fluoroquinolone and the Risk of Aortic Dissection. , 2018, Journal of the American College of Cardiology.

[8]  J. Coselli,et al.  Effect of Ciprofloxacin on Susceptibility to Aortic Dissection and Rupture in Mice , 2018, JAMA surgery.

[9]  H. Svanström,et al.  Fluoroquinolone use and risk of aortic aneurysm and dissection: nationwide cohort study , 2018, British Medical Journal.

[10]  Yueh-Sheng Chen,et al.  Risk of Aortic Dissection and Aortic Aneurysm in Patients Taking Oral Fluoroquinolone. , 2015, JAMA internal medicine.

[11]  D. Redelmeier,et al.  Fluoroquinolones and collagen associated severe adverse events: a longitudinal cohort study , 2015, BMJ Open.

[12]  I. Kullo,et al.  Aortic pulse wave velocity is associated with measures of subclinical target organ damage. , 2011, JACC. Cardiovascular imaging.

[13]  Magdi H. Yacoub,et al.  Cellular and molecular mechanisms of thoracic aortic aneurysms , 2009, Nature Reviews Cardiology.

[14]  P. Fedak,et al.  Induction of human aortic myofibroblast‐mediated extracellular matrix dysregulation: A potential mechanism of fluoroquinolone‐associated aortopathy , 2019, The Journal of thoracic and cardiovascular surgery.